Article
Characterization of the molecular genetic pathology in patients with 11β-hydroxylase deficiency.
Clinical endocrinology - 1 Nov 2015
Mooij Christiaan F, Parajes Silvia, Rose Ian T, Taylor Angela E, Bayraktaroglu Taner, Wass John A H, Connell John M C, Ray David W, Arlt Wiebke, Krone Nils
Abstract excerpt
OBJECTIVE: Steroid 11β-hydroxylase (CYP11B1) deficiency (11OHD) is the second most common form of congenital adrenal hyperplasia. Nonclassic or mild 11OHD appears to be a rare condition. Our study assessed the residual CYP11B1 function of detected mutations, adding to the spectrum of mild 11OHD, and illustrates the variability of the clinical presentation of 11OHD. PATIENTS AND METHODS: Five patients presented...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
